Pingchao Xiang
Overview
Explore the profile of Pingchao Xiang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang Z, Dai Y, Chang J, Xiang P, Liang Z, Yin Y, et al.
Int J Chron Obstruct Pulmon Dis
. 2024 Sep;
19:2097-2107.
PMID: 39346629
Background: Tuberculosis and chronic obstructive pulmonary disease (COPD) are significant public health challenges, with pulmonary tuberculosis recognized as a pivotal risk factor for the development of COPD. Tuberculosis-associated COPD is...
2.
Chang C, Zhang X, Feng Y, Jin R, Sun L, Liang Y, et al.
J Asthma
. 2023 Jun;
60(12):2111-2120.
PMID: 37272671
Objective: Both patients and physicians may be hesitant toward vaccination in patients with asthma, which may result in lower vaccine uptake. The aim of this work was to investigate the...
3.
Wang H, Yuan P, Tang C, Guan Z, Xiang P, Chen X, et al.
Inquiry
. 2022 Apr;
59:469580211055621.
PMID: 35393869
By September 20, 2021, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been pandemic in 237 countries and regions, resulting in 228,506,698 confirmed cases and 4,692,361 deaths. At the same...
4.
Song Z, Liu X, Xiang P, Lin Y, Dai L, Guo Y, et al.
Int J Chron Obstruct Pulmon Dis
. 2021 Dec;
16:3337-3346.
PMID: 34949917
Background: SARS-CoV-2 tends to cause more severe disease in patients with COPD once they are infected. We aimed to investigate the rates of influenza, pneumococcal and COVID-19 vaccination uptake in...
5.
Diao W, Labaki W, Han M, Yeomans L, Sun Y, Smiley Z, et al.
Int J Chron Obstruct Pulmon Dis
. 2019 Oct;
14:2015-2025.
PMID: 31564849
Background: Chronic obstructive pulmonary disease (COPD) is a systemic condition that is too complex to be assessed by lung function alone. Metabolomics has the potential to help understand the mechanistic...
6.
Zhou F, Wang Y, Liu Y, Liu X, Gu L, Zhang X, et al.
Eur Respir J
. 2019 Jun;
54(2).
PMID: 31164430
Although broad knowledge of influenza viral pneumonia has been established, the significance of non-influenza respiratory viruses in community-acquired pneumonia (CAP) and their impact on clinical outcomes remains unclear, especially in...
7.
Zhou T, Zhong Y, Liao J, Wang G, Li X, Qian X, et al.
BMC Pulm Med
. 2019 Jan;
19(1):22.
PMID: 30683080
Background: Chronic Obstructive Pulmonary Disease (COPD) is a major cause of morbidity and mortality all over the world. Acute exacerbation of COPD (AECOPD) not only accelerates the progression of disease,...
8.
Yang H, Xiang P, Zhang E, Guo W, Shi Y, Zhang S, et al.
BMJ Open
. 2015 Dec;
5(12):e008909.
PMID: 26671953
Objectives: To assess whether hypercapnia may predict the prognosis in chronic obstructive pulmonary disease (COPD). Design: Prospective cohort study comparing the survival of patients with COPD and normocapnia to those...
9.
Yang H, Xiang P, Zhang E, Guo W, Shi Y, Zhang S, et al.
Eur J Med Res
. 2014 Apr;
19:18.
PMID: 24713440
Background: Exacerbations of chronic obstructive pulmonary disease (COPD) are sporadic, acute worsening of symptoms. Identifying predictors of exacerbation frequency may facilitate medical interventions that reduce exacerbation frequency and severity. The...